OCC 2.92% 66.5¢ orthocell limited

Ann: Positive Data for CelGro Collagen Rope in ACL Reconstruction, page-34

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 7,895 Posts.
    lightbulb Created with Sketch. 7130
    Just be patient Hotdog11. You've waited years. The markets are fickle and stupid at times. We are almost there.

    OCC is FDA/TGA/EMA approved in CelGro Bone (Dental: Straite) and deep in US partnership discussions
    OCC has 510(k) requirements for CelGro Nerve - we know the company is talking to the FDA about the most best remuneration avenue for approval
    OCC is on the verge of announcing (hopefully October) four year pivotal RCT results that could seal a partnership with the biggest Pharma company in the world.
    OCC has just announced very good pre-clinical results in its ACL graft, including be able to withstand higher tensile forces that an autologous hamstring graft, the present preferred method amongst Surgeons who literally have no alternatives.

    That this stock trades here is silly. With the host of announcements coming in the next quarter this stock should finally get some positive leverage in the financial media and hopefully see some solid share price gains.
 
watchlist Created with Sketch. Add OCC (ASX) to my watchlist
(20min delay)
Last
66.5¢
Change
-0.020(2.92%)
Mkt cap ! $159.0M
Open High Low Value Volume
67.0¢ 67.0¢ 65.0¢ $245.7K 371.8K

Buyers (Bids)

No. Vol. Price($)
2 15000 65.5¢
 

Sellers (Offers)

Price($) Vol. No.
66.5¢ 12621 2
View Market Depth
Last trade - 16.10pm 13/11/2024 (20 minute delay) ?
OCC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.